Ribozyme Pharmaceuticals, Incorporated

Ribozyme Pharmaceuticals, incorporated is a leading biopharmaceutical company specialized in developing novel RNA-based therapeutics. We leverage the unique catalytic properties of ribozymes to create innovative drugs for a wide range of diseases, including genetic disorders, cancer, and viral infections. Our dedicated team of scientists and researchers work tirelessly to discover and optimize ribozyme-based therapies that have the potential to revolutionize healthcare. Visit our website to learn more about our cutting-edge developments and commitment to improving patient outcomes.